The Drug Administration Department ( Ministry of Health ) has issued Decision No. 46/QD-QLD regarding the recall of Diacerin 50 hard capsule tablets (Diacerein 50mg), registration number 893110447024, batch number 0125, production date 20/04/2025, expiry date 20/04/2028, manufactured by the Medical Pharmaceutical and Biological Joint Stock Company Branch.
The decision was made based on the test results from the Thanh Hoa Testing Center and the Ho Chi Minh City Institute of Drug Testing. Accordingly, the Diacerin 50 sample failed to meet quality standards regarding water content, and was determined to be a level 3 violation as stipulated in Circular No. 30/2025/TT-BYT.
The Drug Administration Department has ordered the recall of the entire batch of the aforementioned drug nationwide. The manufacturing company must cease sales, quarantine any remaining stock, organize the recall within 15 days of the decision, and be responsible for handling the recalled batch in accordance with the law.
Wholesale and retail establishments, medical examination and treatment facilities, and users are required to cease trading, dispensing, and using the recalled batch of Diacerin 50; and to return the medicine to the supplier.
The Departments of Health of provinces and centrally-administered cities are responsible for widely publicizing recall information, posting it on their websites, inspecting and monitoring implementation, and handling violations according to regulations.
Source: https://baolaocai.vn/thu-hoi-toan-quoc-lo-thuoc-diacerin-50-vi-pham-chat-luong-muc-do-3-post892185.html
Comment (0)